ストックスクリーナーアプリを入手
83.59
0.49%
0.405
アフターアワーズ：
83.68
0.085
+0.10%
前日終値:
$83.19
開ける：
$83.07
24時間の取引高:
263.86K
Relative Volume:
1.30
時価総額：
$1.22B
収益：
$1.30M
当期純損益:
$-140.06M
株価収益率:
-9.243
EPS:
-9.0441
ネットキャッシュフロー:
$-129.83M
1週間 パフォーマンス:
+24.53%
1か月 パフォーマンス:
+21.61%
6か月 パフォーマンス:
+132.60%
1年 パフォーマンス:
+609.03%
1日の値動き範囲:
$79.77
$85.94
1週間の範囲:
$66.41
$85.94
52週間の値動き範囲:
$10.84
$94.56
Inhibrx Biosciences Inc Stock (INBX) Company Profile
名前
Inhibrx Biosciences Inc
セクター
電話
(858) 795-4220
住所
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Compare INBX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
83.59 | 1.22B | 1.30M | -140.06M | -129.83M | -9.0441 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-08 | 開始されました | Stifel | Buy |
| 2024-07-23 | 開始されました | JMP Securities | Mkt Perform |
| 2024-01-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 開始されました | SMBC Nikko | Outperform |
| 2021-09-21 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Inhibrx Biosciences Inc (INBX) 最新ニュース
Avoiding Lag: Real-Time Signals in (INBX) Movement - Stock Traders Daily
Insider Sell: Whats the beta of Inhibrx Biosciences Inc stockRecession Risk & Real-Time Volume Analysis - baoquankhu1.vn
Top Cybin (HELP) Competitors 2026 - MarketBeat
Does Stifel’s Focus on Ozekibart Milestones Reframe Inhibrx Biosciences' (INBX) Core Oncology Narrative? - simplywall.st
A Look At Inhibrx Biosciences (INBX) Valuation After Stifel Nicolaus Initiates Buy Coverage - Sahm
Weekly Recap: Is Inhibrx Biosciences Inc affected by consumer sentimentWeekly Earnings Recap & Real-Time Buy Signal Notifications - baoquankhu1.vn
This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Sahm
Stifel initiates coverage of Inhibrx Biosciences (INBX) with buy recommendation - MSN
Inhibrx stock gains as Stifel issues new Buy (INBX:NASDAQ) - Seeking Alpha
Inhibrx Biosciences advances efforts targeting rare sarcoma cancers - Traders Union
INBX Should I Buy - Intellectia AI
Discipline and Rules-Based Execution in INBX Response - Stock Traders Daily
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Down 5.7%What's Next? - MarketBeat
US Market Recap: Will Inhibrx Biosciences Inc stock recover after earnings2026 Risk Factors & Verified Momentum Watchlists - baoquankhu1.vn
Fundamentals Check: Will Inhibrx Biosciences Inc stock go up in YEAR2026 Opening Moves & Daily Volume Surge Signals - baoquankhu1.vn
Value Recap: Does Inhibrx Biosciences Inc have consistent dividend growthInsider Selling & Weekly Setup with ROI Potential - baoquankhu1.vn
Inhibrx Biosciences Inc. (INBX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Inhibrx Biosciences partners with Sarcoma Alliance to advance patient education resources - Traders Union
Retail Trends: Is Inhibrx Biosciences Inc stock undervalued right now2026 Earnings Impact & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Volume Recap: Is Inhibrx Biosciences Inc affected by consumer sentimentTrend Reversal & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Inhibrx Biosciences FY25 Review: Catalyst-Driven Hold Ahead Of Key 2026 Data (INBX) - Seeking Alpha
Ideas Watch: Is Inhibrx Biosciences Inc stock undervalued right nowEarnings Performance Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Down 6.6%Here's Why - marketbeat.com
Inhibrx Biosciences (INBX) Expected to Announce Earnings on Tuesday - MarketBeat
Behavioral Patterns of INBX and Institutional Flows - Stock Traders Daily
Inhibrx Biosciences Reports 2025 Financial Results - Intellectia AI
Inhibrx Reports Q4 Revenue of $0, Cash Balance at $124.2M - Intellectia AI
Inhibrx Biosciences Reports Q4 Earnings Miss - Intellectia AI
INBX SEC FilingsInhibrx Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Inhibrx Inc stock surges on Q4 2025 earnings and key 2026 pipeline milestones - ad-hoc-news.de
Inhibrx Biosciences, Inc. 2025 Annual Report – Clinical Pipeline, Regulatory Progress, and Company Overview - Minichart
Inhibrx Biosciences (NASDAQ:INBX) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Inhibrx Biosciences Q4 net loss narrows as expenses fall - TradingView
Inhibrx Biosciences 10-K: $1.3M revenue, EPS $(9.04) - TradingView
[10-K] Inhibrx Biosciences, Inc. Files Annual Report | INBX SEC FilingForm 10-K - Stock Titan
Inhibrx Biosciences (NASDAQ: INBX) details 2025 loss and 2026 trial plans - Stock Titan
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results - Nasdaq
Cancer drug filing tops Inhibrx milestones as cash reaches $124.2M - Stock Titan
Stock Analysis: Is Inhibrx Biosciences Inc a turnaround story2026 Key Lessons & High Accuracy Trade Alerts - baoquankhu1.vn
Boothbay Fund Management LLC Boosts Holdings in Inhibrx Biosciences, Inc. $INBX - marketbeat.com
Growth Value: What is Inhibrx Biosciences Incs P E ratio telling usQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Latest INBX NewsInhibrx Announces Participation in Upcoming... - Stock Titan
Slotnik Capital LLC Sells 142,770 Shares of Inhibrx Biosciences, Inc. $INBX - MarketBeat
Inhibrx Biosciences Inc expected to post a loss of $2.08 a shareEarnings Preview - TradingView
(INBX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Inhibrx Biosciences : ESMO Sarcoma and Rare Cancers Congress 2026 (INBRX-109 in Ewing sarcoma Data Update Oral Presentation) - marketscreener.com
Market Trends: Is Inhibrx Biosciences Inc stock undervalued right now2026 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Inhibrx Biosciences (INBX) to Release Quarterly Earnings on Monday - MarketBeat
Will Inhibrx Biosciences Inc stock recover after earnings2025 Key Lessons & Technical Pattern Based Buy Signals - baoquankhu1.vn
Inhibrx Announces Participation in Upcoming Scientific Conference - PR Newswire
How (INBX) Movements Inform Risk Allocation Models - Stock Traders Daily
Inhibrx Biosciences Inc (INBX) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):